6-Chloro-2-(difluoromethoxy)nicotinic acid, 97%, 250mg

5-((3aS,4S,6aR)-2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-N-(prop-2-yn-1-yl)pentanamide, 95+%, 250mg

N-(4-Methyl-3-nitrophenyl)-4-(trifluoromethyl)benzamide, 97.0%, 100mg

N-(6-Bromohexyl)phthalimide>98.0%(GC)5g

Provette di coltura in polipropilene con graduazioni, 14 ml, 17 mm, 500 x 1 500 pezzi

4-Acetamido-N-(4-methoxyphenyl)benzenesulfonamide, 95.0%, 5g

4-[(1R)-1-[[(Phenylmethoxy)carbonyl]amino]ethyl]benzoic acid, 98%, 250mg

1-BOC-5-(BENZYLOXY)-3-METHYL-1H-PYRAZOLO[3,4-C]PYRIDINE, 97.0%, 100mg

3-Phenyl-[1,2,4]oxadiazole-5-carboxylic acid ethyl ester, 95.0%, 1g

5-chloro-1H-1,2,4-triazole-3-carboxylic acid N,N-diethylethanamine salt, 95.0%, 1g

Colonna Vigreux con guscio sottovuoto fuso, 200 mm, 14/23, 1 Pezzo

2-Methyl-2H-indazole-4-boronic acid, pinacol ester, 96.0%, 250mg

1-(2-Fluoroethyl)-3-methyl-1H-pyrazol-5-amine hydrochloride, 1g